Back to Browse Journals » Vascular Health and Risk Management » Volume 4 » Issue 2

Expert review on coronary calcium

Authors Matthew J Budoff, Khawar M Gul

Published Date May 2008 Volume 2008:4(2) Pages 315—324

DOI http://dx.doi.org/10.2147/VHRM.S1160

Published 5 May 2008

Matthew J Budoff, Khawar M Gul

Division of Cardiology, Saint John’s Cardiovascular Research Center, Los Angeles Biomedical Research Institute at Harbor-UCLA, Torrance, California, USA

Abstract: While there is no doubt that high risk patients (those with >20% ten year risk of future cardiovascular event) need more aggressive preventive therapy, a majority of cardiovascular events occur in individuals at intermediate risk (10%–20% ten year risk). Accurate risk assessment may be helpful in decreasing cardiovascular events through more appropriate targeting of preventive measures. It has been suggested that traditional risk assessment may be refined with the selective use of coronary artery calcium (CAC) or other methods of subclinical atherosclerosis measurement. Coronary calcification is a marker of atherosclerosis that can be quantified with the use of cardiac CT and it is proportional to the extent and severity of atherosclerotic disease. The published studies demonstrate a high sensitivity of CAC for the presence of coronary artery disease but a lower specificity for obstructive CAD depending on the magnitude of the CAC. Several large clinical trials found clear, incremental predictive value of CAC over the Framingham risk score when used in asymptomatic patients. Based on multiple observational studies, patients with increased plaque burdens (increased CAC) are approximately ten times more likely to suffer a cardiac event over the next 3–5 years. Coronary calcium scores have outperformed conventional risk factors, highly sensitive C-reactive protein (CRP) and carotid intima media thickness (IMT) as a predictor of cardiovascular events. The relevant prognostic information obtained may be useful to initiate or intensify appropriate treatment strategies to slow the progression of atherosclerotic vascular disease. Current data suggests intermediate risk patients may benefit most from further risk stratification with cardiac CT, as CAC testing is effective at identifying increased risk and in motivating effective behavioral changes. This article reviews information pertaining to the clinical use of CAC for assessing coronary atherosclerosis as a useful predictor of coronary artery disease (CAD) in certain population of patients.

Keywords: computed tomography, electron beam, prognosis, review, coronary artery calcification, calcium score, atherosclerosis, multi-detector computed tomography

Download Article [PDF] 

Creative Commons License This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution - Non Commercial (unported, v3.0) License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at: http://www.dovepress.com/permissions.php

Other article by this author:

Mild and moderate pre-dialysis chronic kidney disease is associated with increased coronary artery calcium

Roy SK, Cespedes A, Li D, Choi TY, Budoff MJ

Vascular Health and Risk Management 2011, 7:719-724

Published Date: 2 December 2011

Readers of this article also read:

A score to predict short-term risk of COPD exacerbations (SCOPEX)

Make BJ, Eriksson G, Calverley PM, Jenkins CR, Postma DS, Peterson S, Östlund O, Anzueto A

International Journal of Chronic Obstructive Pulmonary Disease 2015, 10:201-209

Published Date: 27 January 2015

Developmental dyslexia and vision

Quercia P, Feiss L, Michel C

Clinical Ophthalmology 2013, 7:869-881

Published Date: 14 May 2013

Topical dorzolamide for macular edema in the early phase after vitrectomy and epiretinal membrane removal

Suzuki T, Hayakawa K, Nakagawa Y, Onouchi H, Ogata M, Kawai K

Clinical Ophthalmology 2013, 7:549-553

Published Date: 19 April 2013

The relationship between alexithymia, shame, trauma, and body image disorders: investigation over a large clinical sample

Franzoni E, Gualandi S, Caretti V, Schimmenti A, Di Pietro E, Pellegrini G, Craparo G, Franchi A, Verrotti A, Pellicciari A

Neuropsychiatric Disease and Treatment 2013, 9:185-193

Published Date: 18 February 2013

Outcomes of patients treated with the everolimus-eluting stent versus the zotarolimus-eluting stent in a consecutive cohort of patients at a tertiary medical center

Shammas NW, Shammas GA , Nader E, Jerin M, Mrad L, Marogil P, Henn C, Dvorak A, Chintalapani A, Meriner S

Vascular Health and Risk Management 2012, 8:205-211

Published Date: 11 April 2012

Corneal abrasion

Scott Fraser

Clinical Ophthalmology 2010, 4:387-390

Published Date: 26 April 2010

Effects of allopurinol and vitamin E on renal function in patients with cardiac coronary artery bypass grafts

Nader Nouri-Majalan, Ehsan Fotouhi Ardakani, Khalil Forouzannia, Hosein Moshtaghian

Vascular Health and Risk Management 2009, 5:489-494

Published Date: 27 May 2009